A retrospective series of long-term survivors of metastatic breast cancer in complete remission

Oncology. 2005;68(1):48-51. doi: 10.1159/000084819. Epub 2005 Mar 7.

Abstract

Aim: To describe clinical features, treatment modalities and long-term outcome of patients with overt metastatic breast cancer in complete remission for more than 5 years.

Patients and methods: A retrospective survey of 12 patients who were referred to a single institution from 1982 to 1995.

Results: The majority of the long-term survivors had a good performance status, endocrine-responsive disease and a single metastatic site. Ten patients had received chemotherapy, 8 patients hormone therapy, and 2 patients had been treated with surgery followed by systemic therapies. At a median follow-up of 11.7 years, 10 of the 12 patients were still in complete remission. The median duration of complete remission was 9.2 years (range 5.0-15.7 years).

Conclusions: This case series confirms that only a few metastatic breast cancer patients could potentially be cured with multidisciplinary treatments.

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms / mortality
  • Breast Neoplasms / pathology*
  • Breast Neoplasms / therapy*
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Middle Aged
  • Radiotherapy, Adjuvant
  • Retrospective Studies
  • Survivors
  • Time Factors

Substances

  • Antineoplastic Agents
  • Antineoplastic Agents, Hormonal